Ivana Gojo, MD | Authors

A Phase I Study of Paclitaxel, UFT, and Leucovorin

October 01, 2000

This phase I study examines the dose escalation of UFT given in combination with fixed doses of oral leucovorin and weekly doses of paclitaxel in patients with metastatic solid tumor malignancies (excluding colorectal cancer). There are two main objectives for this study.